• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在纽约市,将 COVID-19 疫苗接种的优先级赋予高危人群,以抵消优先级所导致的瓶颈的严重程度,需要达到何种程度?

How severe would prioritization-induced bottlenecks need to be offset the benefits from prioritizing COVID-19 vaccination to those most at risk in New York City?

机构信息

Department of Population Health, New York University Grossman School of Medicine, 227 E 30th Street, NY, 10016, New York, USA.

出版信息

BMC Public Health. 2023 Jan 26;23(1):174. doi: 10.1186/s12889-022-14846-7.

DOI:10.1186/s12889-022-14846-7
PMID:36698103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9876757/
Abstract

BACKGROUND

Prioritization of higher-risk people for COVID-19 vaccination could prevent more deaths, but could slow vaccination speed. We used mathematical modeling to examine the trade-off between vaccination speed and prioritization for individuals age 65+ and essential workers.

METHODS

We used a stochastic, discrete-time susceptible-exposed-infected-recovered (SEIR) model with age- and comorbidity-adjusted COVID-19 outcomes (infections, hospitalizations, and deaths). The model was calibrated to COVID-19 hospitalizations, ICU census, and deaths in NYC. We assumed 10,000 vaccinations per day, initially restricted to healthcare workers and nursing home populations, and subsequently expanded to other populations at alternative times (4, 5, or 6 weeks after vaccine launch) and speeds (20,000, 50,000, 100,000, or 150,000 vaccinations per day), as well as prioritization options (+/- prioritization of people age 65+ and essential workers). In sensitivity analyses, we examined the effect of a SARS-COV-2 variant with greater transmissibility.

RESULTS

To be beneficial, prioritization must not create a bottleneck that decreases vaccination speed by > 50% without a more transmissible variant, or by > 33% with the emergence of the more transmissible variant. More specifically, prioritizing people age 65+ and essential workers increased the number of lives saved per vaccine dose delivered: 3000 deaths could be averted by delivering 83,000 vaccinations per day without prioritization or 50,000 vaccinations per day with prioritization. Other tradeoffs involve vaccination speed and timing. Compared to the slowest-examined vaccination speed of 20,000 vaccinations per day, achieving the fastest-examined vaccination speed of 150,000 vaccinations per day would avert additional 313,700 (28.6%) infections and 1693 (24.1%) deaths. Emergence of a more transmissible variant would double COVID-19 infections, hospitalizations, and deaths over the first 6 months of vaccination. The fastest-examined vaccination speed could only offset the harm of the more transmissible variant if achieved within 5 weeks of vaccine launch.

CONCLUSIONS

Faster vaccination speed with sooner vaccination expansion would save more lives. Prioritization of COVID-19 vaccines to higher-risk populations would be more beneficial only if it does not create an excessive vaccine delivery bottleneck.

摘要

背景

为 COVID-19 疫苗接种的高风险人群进行优先排序可以预防更多的死亡,但可能会减缓疫苗接种速度。我们使用数学模型来研究为 65 岁以上人群和基本工作人员进行疫苗接种的优先排序与疫苗接种速度之间的权衡。

方法

我们使用了一个具有年龄和合并症调整的 COVID-19 结果(感染、住院和死亡)的随机、离散时间易感性-暴露-感染-恢复(SEIR)模型。该模型根据纽约市的 COVID-19 住院、重症监护病房人数和死亡人数进行了校准。我们假设每天接种 10000 剂疫苗,最初仅限于医护人员和养老院人群,随后在不同时间(疫苗推出后 4、5 或 6 周)和不同速度(每天 20000、50000、100000 或 150000 剂疫苗)扩大到其他人群,并进行了优先排序选项(是否优先考虑 65 岁以上人群和基本工作人员)。在敏感性分析中,我们研究了一种具有更高传染性的 SARS-COV-2 变体的影响。

结果

要具有益处,优先排序不得在没有更具传染性的变体的情况下,将疫苗接种速度降低超过 50%,或者在出现更具传染性的变体的情况下降低超过 33%。更具体地说,优先考虑 65 岁以上人群和基本工作人员可以增加每接种一剂疫苗所挽救的生命数量:不进行优先排序每天可接种 83000 剂疫苗,或每天接种 50000 剂疫苗可避免 3000 人死亡。其他权衡涉及疫苗接种速度和时间。与我们研究的最慢接种速度 20000 剂疫苗相比,实现最快的接种速度 150000 剂疫苗每天可额外避免 313700(28.6%)感染和 1693(24.1%)死亡。更具传染性变体的出现将使 COVID-19 在接种疫苗的前 6 个月内的感染、住院和死亡人数增加一倍。只有在疫苗推出后 5 周内达到最快的接种速度,才能抵消更具传染性变体的危害。

结论

更快的疫苗接种速度和更早的疫苗接种推广将挽救更多生命。只有在不造成疫苗接种过度瓶颈的情况下,为高风险人群接种 COVID-19 疫苗进行优先排序才会更有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/9878863/137508a1883f/12889_2022_14846_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/9878863/279f9ba8d7ad/12889_2022_14846_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/9878863/4ce9c52844e5/12889_2022_14846_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/9878863/137508a1883f/12889_2022_14846_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/9878863/279f9ba8d7ad/12889_2022_14846_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/9878863/4ce9c52844e5/12889_2022_14846_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/9878863/137508a1883f/12889_2022_14846_Fig3_HTML.jpg

相似文献

1
How severe would prioritization-induced bottlenecks need to be offset the benefits from prioritizing COVID-19 vaccination to those most at risk in New York City?在纽约市,将 COVID-19 疫苗接种的优先级赋予高危人群,以抵消优先级所导致的瓶颈的严重程度,需要达到何种程度?
BMC Public Health. 2023 Jan 26;23(1):174. doi: 10.1186/s12889-022-14846-7.
2
Evaluating primary and booster vaccination prioritization strategies for COVID-19 by age and high-contact employment status using data from contact surveys.基于接触者调查数据评估 COVID-19 的基础免疫和加强免疫优先接种策略:按年龄和高接触职业状况分层。
Epidemics. 2023 Jun;43:100686. doi: 10.1016/j.epidem.2023.100686. Epub 2023 May 3.
3
Lives saved and hospitalizations averted by COVID-19 vaccination in New York City: a modeling study.纽约市新冠疫苗接种所挽救的生命及避免的住院情况:一项建模研究
Lancet Reg Health Am. 2022 Jan;5:100085. doi: 10.1016/j.lana.2021.100085. Epub 2021 Oct 30.
4
COVID-19 vaccinations and rates of infections, hospitalizations, ICU admissions, and deaths in Europe during SARS-CoV-2 Omicron wave in the first quarter of 2022.2022 年第一季度,在欧洲 SARS-CoV-2 奥密克戎波期间,COVID-19 疫苗接种率与感染、住院、重症监护病房入院和死亡。
J Med Virol. 2023 Jan;95(1):e28131. doi: 10.1002/jmv.28131. Epub 2022 Sep 14.
5
Impact of vaccine prioritization strategies on mitigating COVID-19: an agent-based simulation study using an urban region in the United States.疫苗优先接种策略对缓解 COVID-19 的影响:基于美国一个城市地区的基于代理的模拟研究。
BMC Med Res Methodol. 2021 Dec 5;21(1):272. doi: 10.1186/s12874-021-01458-9.
6
COVID-19 epidemic in New York City: development of an age group-specific mathematical model to predict the outcome of various vaccination strategies.纽约市的 COVID-19 疫情:开发一种特定年龄组的数学模型,以预测各种疫苗接种策略的结果。
Virol J. 2022 Mar 15;19(1):43. doi: 10.1186/s12985-022-01771-9.
7
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
8
Considerations for fair prioritization of COVID-19 vaccine and its mandate among healthcare personnel.医疗保健人员 COVID-19 疫苗公平优先排序及其授权的考虑因素。
Curr Med Res Opin. 2021 Jun;37(6):907-909. doi: 10.1080/03007995.2021.1908245. Epub 2021 Apr 9.
9
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州,2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
10
Vaccinations Against COVID-19 May Have Averted Up To 140,000 Deaths In The United States.接种 COVID-19 疫苗可能使美国避免了多达 14 万人死亡。
Health Aff (Millwood). 2021 Sep;40(9):1465-1472. doi: 10.1377/hlthaff.2021.00619. Epub 2021 Aug 18.

本文引用的文献

1
Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.COVID-19 相关死亡风险因素:42 项研究和 423117 例患者的系统评价和荟萃分析。
BMC Infect Dis. 2021 Aug 21;21(1):855. doi: 10.1186/s12879-021-06536-3.
2
Modelling optimal vaccination strategy for SARS-CoV-2 in the UK.在英国建立 SARS-CoV-2 的最佳疫苗接种策略模型。
PLoS Comput Biol. 2021 May 6;17(5):e1008849. doi: 10.1371/journal.pcbi.1008849. eCollection 2021 May.
3
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.
评估 SARS-CoV-2 谱系 B.1.1.7 在英国的传播能力。
Nature. 2021 May;593(7858):266-269. doi: 10.1038/s41586-021-03470-x. Epub 2021 Mar 25.
4
The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine - United States, December 2020.免疫实践咨询委员会更新的 COVID-19 疫苗分配临时建议-美国,2020 年 12 月。
MMWR Morb Mortal Wkly Rep. 2021 Jan 1;69(5152):1657-1660. doi: 10.15585/mmwr.mm695152e2.
5
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
6
COVID-19 Outbreak - New York City, February 29-June 1, 2020.COVID-19 疫情爆发 - 纽约市,2020 年 2 月 29 日至 6 月 1 日。
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1725-1729. doi: 10.15585/mmwr.mm6946a2.
7
Will an imperfect vaccine curtail the COVID-19 pandemic in the U.S.?一种并不完美的疫苗能遏制美国的新冠疫情吗?
Infect Dis Model. 2020;5:510-524. doi: 10.1016/j.idm.2020.07.006. Epub 2020 Aug 6.
8
Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes.COVID-19 流行病学:临床特征、危险因素和结局的系统评价和荟萃分析。
J Med Virol. 2021 Mar;93(3):1449-1458. doi: 10.1002/jmv.26424. Epub 2020 Aug 25.
9
Secondary attack rate of COVID-19 in household contacts: a systematic review.家庭接触者中 COVID-19 的二次发病(攻击)率:一项系统综述。
QJM. 2020 Dec 1;113(12):841-850. doi: 10.1093/qjmed/hcaa232.
10
Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies.新型冠状病毒病 2019(COVID-19)感染患者死亡的危险因素:观察性研究的系统评价和荟萃分析。
Aging Male. 2020 Dec;23(5):1416-1424. doi: 10.1080/13685538.2020.1774748. Epub 2020 Jun 8.